Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
Answer:
The A band stays the same width and, at full contraction, the thin filaments overlap. ... The I band contains only thin filaments and also shortens. The A band does not shorten—it remains the same length—but A bands of different sarcomeres move closer together during contraction, eventually disappearing.
Answer:
The correct answer is C. In addition to producing an influenza protein from an inserted gene, the egg cells will produce proteins that cause an allergic reaction in some people.
Explanation:
Chicken eggs are full of proteins, in order to carry the embryo successfully. But, when treated genetically, some proteins can start to be produced causing some allergies, combined with the proteins that are already produced that can already cause allergies.
